Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Malignant Lymphoma

Free Subscription 21.10.2024 2 Am J Hematol 7 Br J Haematol 2 Eur J Haematol 1 Haematologica 1 Hum Pathol 3 Leuk Lymphoma 1 Leukemia 2 N Engl J Med 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Hematol

1. 
   Abstracts from the 2024 Lymphoma Leukemia and Myeloma Congress October 16-19, 2024.
   Am J Hematol. 2024;99 Suppl 2:S3-S64.
   PubMed        
   
   
2. ATALLAH-YUNES SA, Rees MJ, Mwangi R, Kuchler RL, et al
   Characteristics and outcomes of incidentally diagnosed diffuse large B-cell lymphoma and implications for cancer screening.
   Am J Hematol. 2024 Oct 14. doi: 10.1002/ajh.27504.
   PubMed         Abstract available
   
   

   
   Br J Haematol

3. YOSHIMITSU M, Tanaka T, Nakano N, Kato K, et al
   Comparative outcomes of various transplantation platforms, highlighting haploidentical transplants with post-transplantation cyclophosphamide for adult T-cell leukaemia/lymphoma.
   Br J Haematol. 2024 Oct 19. doi: 10.1111/bjh.19835.
   PubMed         Abstract available
   
   
4. BUCCHERI V, Moreira FR, Biasoli I, Castro N, et al
   External validation and calibration of the HoLISTIC Consortium's advanced-stage Hodgkin lymphoma international prognostic index (A-HIPI) in the Brazilian Hodgkin lymphoma registry.
   Br J Haematol. 2024 Oct 17. doi: 10.1111/bjh.19824.
   PubMed         Abstract available
   
   
5. LE GALLO M, Rose J, Safa F, Cottin L, et al
   Bone marrow metastasis of rhabdomyosarcoma mimicking high-grade lymphoma in a young man.
   Br J Haematol. 2024 Oct 15. doi: 10.1111/bjh.19795.
   PubMed        
   
   
6. CHIRIAC R, Baseggio L
   Monomorphic epitheliotropic intestinal T-cell lymphoma involving the aqueous humour.
   Br J Haematol. 2024 Oct 14. doi: 10.1111/bjh.19806.
   PubMed        
   
   
7. BARRACLOUGH A, Lee ST, Villa D, Hapgood G, et al
   The value of semiquantitative PET features and end-of-therapy PET in grade 3B follicular lymphoma.
   Br J Haematol. 2024 Oct 13. doi: 10.1111/bjh.19823.
   PubMed         Abstract available
   
   
8. WU S, Luo Q, Li F, Zhang S, et al
   Development of novel humanized CD19/BAFFR bicistronic chimeric antigen receptor T cells with potent antitumor activity against B-cell lineage neoplasms.
   Br J Haematol. 2024;205:1361-1373.
   PubMed         Abstract available
   
   
9. BARONE A, Chiappella A, Casadei B, Bramanti S, et al
   Secondary primary malignancies after CD-19 directed CAR-T-cell therapy in lymphomas: A report from the Italian CART-SIE study.
   Br J Haematol. 2024;205:1356-1360.
   PubMed         Abstract available
   
   

   
   Eur J Haematol

10. ANDERSEN MD, Wolter K, Enemark MBH, Pedersen MA, et al
    Proteomic Profiling of Lymph Nodes Differentiates Classic Hodgkin Lymphoma With and Without Skeletal Involvement.
    Eur J Haematol. 2024 Oct 11. doi: 10.1111/ejh.14326.
    PubMed         Abstract available
    
    
11. LIEVIN R, Burroni B, Balducci E, Palmic P, et al
    Biological Findings and Clinical Outcomes in Patients Treated With R-CHOP Plus High-Dose Methotrexate as First-Line Therapy in Large B-Cell Lymphoma With Testis Involvement.
    Eur J Haematol. 2024 Oct 12. doi: 10.1111/ejh.14325.
    PubMed         Abstract available
    
    

    
    Haematologica

12. BRIEGHEL C, Petersen SL, Brown PN, Niemann CU, et al
    Frequency of secondary T-cell lymphoma in chimeric antigen receptor Tcell naive B-cell lymphoid-lineage cancers is higher than that reported on chimeric antigen receptor T-cell therapy.
    Haematologica. 2024 Oct 17. doi: 10.3324/haematol.2024.286002.
    PubMed         Abstract available
    
    

    
    Hum Pathol

13. XIE W, Medeiros LJ, Fan G, Li S, et al
    Systemic ALK-Negative Anaplastic Large Cell Lymphoma: Insights into Morphologic, Immunophenotypic, Genetic and Molecular Characteristics.
    Hum Pathol. 2024 Oct 16:105671. doi: 10.1016/j.humpath.2024.105671.
    PubMed         Abstract available
    
    

    
    Leuk Lymphoma

14. FASSER D, Lewis K, Leslie C, Cull G, et al
    Indolent relapse after initial aggressive B-cell lymphoma: a single institution experience in the rituximab era.
    Leuk Lymphoma. 2024 Oct 18:1-4. doi: 10.1080/10428194.2024.2416563.
    PubMed        
    
    
15. HAN J, McCall CM, Isom S, Smith WM, et al
    High Ki67 index is associated with shorter progression free survival in patients with Follicular Lymphoma treated with frontline immunochemotherapy.
    Leuk Lymphoma. 2024 Oct 16:1-4. doi: 10.1080/10428194.2024.2414899.
    PubMed        
    
    
16. YANG L, Zeng LJ, Wang S, Wei LQ, et al
    Evaluating early response assessment in extranodal natural killer/T-cell lymphoma by analyzing DeltaSUVlbm between baseline and interim (18)F-FDG PET/CT scans.
    Leuk Lymphoma. 2024 Oct 15:1-8. doi: 10.1080/10428194.2024.2416026.
    PubMed         Abstract available
    
    

    
    Leukemia

17. CORINALDESI C, Holmes AB, Martire G, Tosato A, et al
    Single-cell transcriptomics of pediatric Burkitt lymphoma reveals intra-tumor heterogeneity and markers of therapy resistance.
    Leukemia. 2024 Oct 18. doi: 10.1038/s41375-024-02431.
    PubMed         Abstract available
    
    

    
    N Engl J Med

18. ARMITAGE JO, Longo DL
    Therapy for Hodgkin's Lymphoma - Can It Get Any Better?
    N Engl J Med. 2024;391:1452-1454.
    PubMed        
    
    
19. HERRERA AF, LeBlanc M, Castellino SM, Li H, et al
    Nivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma.
    N Engl J Med. 2024;391:1379-1389.
    PubMed         Abstract available
    
    

    
    PLoS One

20. WANG Q, Huang T, Wei X
    Impact of prior cancer history on the prognosis of extranodal NK/T-cell lymphoma.
    PLoS One. 2024;19:e0311094.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.